Skip to main content
Clinical Trials/NCT00621712
NCT00621712
Completed
N/A

Clinical Assessment of a New Catheter Surface Coating With Antimicrobial Properties: Efficacy and Effect of Intensive Catheter and Exit Site Care Education

Vantive Health LLC1 site in 1 country90 target enrollmentOctober 2007

Overview

Phase
N/A
Intervention
Not specified
Conditions
Renal Insufficiency
Sponsor
Vantive Health LLC
Enrollment
90
Locations
1
Primary Endpoint
Bacterial colonisation of the catheter surface
Status
Completed
Last Updated
last year

Overview

Brief Summary

The study investigates the efficacy of a catheter with antibacterial surface coating in preventing central venous catheter related infection and the effect of an intensive hygiene and catheter care education of the nursing staff on preventing central venous catheter-related infection.

Detailed Description

The risk of catheter-related bloodstream infection depends on catheter type, method and site of insertion, aseptic technique and number of manipulations. To address this problem, efforts have focused on engineering biomaterials and surfaces with antibacterial properties to prevent bacteria adhesion and biofilm formation. In view of the necessity to reduce catheter-related bloodstream infections and of the inadequacy of currently available antimicrobially coated devices, a new antimicrobial catheter surface was developed. Among other factors, the mode and quality of catheter handling and care of exit site is an important aspect with respect to catheter-related infections. The clinical study aims at providing data on antimicrobial efficiency of the 2 types of CE certified double lumen catheters and a supposed additional preventive effect of intense hygiene training on catheter-related infections.

Registry
clinicaltrials.gov
Start Date
October 2007
End Date
December 2010
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • central venous catheter placement
  • Need for extracorporeal renal replacement therapy (acute and chronic renal failure)
  • Age over 18 years
  • Written informed consent
  • Needed catheter length 15 cm or 20 cm

Exclusion Criteria

  • Known infectivity with Hepatitis B Virus (HBV)/Hepatitis C Virus (HCV)/Human Immunodeficiency Virus (HIV)
  • Any infection associated with one or more positive blood cultures within 10 days prior to catheter implantation
  • Bacteremia with a former catheter within 10 days prior to catheter implantation
  • Known pregnancy
  • Lactation
  • Participation in another clinical study during the preceding 30 days

Outcomes

Primary Outcomes

Bacterial colonisation of the catheter surface

Time Frame: at explantation

Secondary Outcomes

  • Blood parameters(during dialysis)
  • Catheter survival(at explantation)
  • Surface deposits of thrombogenic activity(at explantation)
  • Exit site appearance(at routine catheter care)

Study Sites (1)

Loading locations...

Similar Trials